AstraZeneca, MSD sue MSN and Sandoz over Calquence generics
08-02-2022
Cancer centre sues BMS and Ono over alleged patent exploitation
25-06-2019
Pavel Kapysh / Shutterstock.com
Japan-based Ono Pharmaceuticals has sued AstraZeneca, accusing the US pharma company of infringing patents covering an antibody used in cancer treatment.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Ono Pharmaceuticals, AstraZeneca, US pharma company, infringing patents, antibody, cancer treatment
